Purdue Pharma’s Reckoning: $7.4 Billion Settlement Exposes the Toll of OxyContin
The Sackler family and Purdue Pharma’s controversial settlement brings financial reparations to opioid victims but shields billionaires from full accountability.
Honey, let’s talk about a $7.4 billion slap on the wrist disguised as justice. The Sackler family, owners of Purdue Pharma, have finally agreed to a financial settlement over the devastating toll of their infamous product, OxyContin. But here’s the kicker: this historic payout comes with one glaring detail that has folks—rightfully—raising eyebrows. Not only does the settlement absolve the Sackler family of future civil litigation, but it also shines a spotlight on how money can buy you just about anything, including freedom from accountability.
So, what’s really going on here? Let’s dig into the mess, shall we?
Keep reading with a 7-day free trial
Subscribe to Petty AF (Auntie's Files) to keep reading this post and get 7 days of free access to the full post archives.